- Rritual Superfoods, Inc. is positioning itself to supply the emerging demand for high-potential mushrooms dietary elixirs as wellness products that combat stress, enhance immunity against disease and increase mental clarity
- Market analysts predict the overall functional foods industry will reach revenues of $268 billion by 2027, and that the functional mushroom segment will grow at a CAGR of 8.04 percent by 2024 as part of the trend
- Rritual was recently certified by the USDA as an organic product, providing third-party validation Rritual’s quality protocols
- Rritual’s initial product launch includes elixirs containing mushroom and adaptogenic herb blends such as Chaga-Eleuthero, Lion’s Mane-Rhodiola and Reishi-Ashwagandha combinations
The recently concluded election cycle in the United States revealed that a growing number of people, regardless of political affiliation, are continuing to explore their options for boosting their wellness and mental flexibility, even including the use of some products that have long been classified as illegal (https://ibn.fm/0wxgz). As a prime example, Oregon has gained significant attention for passing its measure to legalize the hallucinogenic compound in “magic mushrooms” for mental health treatment in supervised settings (https://ibn.fm/tcM4A).
Rritual Superfoods is pushing to become a leader in an emerging mushroom market, but not the one that’s gaining attention from hallucinogenic users and their opponents. Rather, Rritual is among innovators calling attention to the health benefits of “functional fungi” — the dietary mushrooms that have enjoyed health-promoting status for centuries in Asian countries in particular.
“Mushrooms have long been used in Asia for their ability to improve health, maintain vitality, preserve a youthful appearance, and to counter the adverse health effects of chronic stress,” integrative medicine specialist Dr Andrew Weil told the United Kingdom’s Evening Standard (https://ibn.fm/GdAVg). “Research also demonstrates that a variety of traditional mushrooms possess anti-bacterial, anti-viral and immune-enhancing properties.”
Rritual Superfoods recently announced the launch of three elixir varieties available in 14-stick packs and in 250-gram tubs during the fall, as well as a 14-day variety pack that includes all three formulations. The company’s website indicates that the products are currently sold out, but will be available in North America during the first quarter of 2021 (https://ibn.fm/89522).
The elixirs are a Chaga blend designed to boost the immune system, a Lion’s Mane blend designed to support mental clarity and brain health, and a Reishi blend to boost the body’s ability to fight anxiety. Each elixir blend combines these superfood mushroom varieties with adaptogenic herbal roots and other non-superfood mushrooms engineered to deliver these specific benefits.
“All mushrooms are good for us and contain beneficial levels of antioxidants and other plant chemicals, but those called ‘medicinal’ simply have greater levels,” nutritional therapist Grace Kingswell told the Evening Standard.
Chaga, in particular, is known as the “king of mushrooms” and contains an unusually high level of antioxidants with beta glucan-rich polysaccharides that give it powerful immune system-supporting capacity, whereas Reishi has been used for over 2,000 years in China.
On Nov. 12, the company announced it has secured organic certification from the U.S. Department of Agriculture (“USDA”), hailed by CEO David Kerbel because it provides “trusted, third-party validation of the quality of Rritual’s products,” whereas many wellness products market themselves as containing “all-natural” ingredients, which does not indicate regulatory examination (https://ibn.fm/2FGBV).
People generally turn to wellness-boosting products during the winter season as a means of keeping their energy levels high and health intact when temperatures are colder and the sunshine is less potent, making the next few months a prime time for making Rritual’s products available to the public. Particularly during a period of pandemic-level population infection.
Market analysts predict the general functional foods industry will see $268 billion in revenues by 2027, growing at a CAGR of 6.7 percent until then (https://ibn.fm/7Ycqh). Mordor Intelligence’s analysts predict the global functional mushroom market will grow with a CAGR of 8.04 percent between 2019 and 2024 (https://ibn.fm/cTBzW).
For more information, visit the company’s website at https://investors.wearerritual.com.
“Mental Fitness is a Daily Ritual”
NOTE TO INVESTORS: The latest news and updates relating to Rritual are available in the company’s newsroom at http://ibn.fm/Rritual
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
[email protected]
PsychedelicNewsWire is part of the InvestorBrandNetwork.